Document is current
Any future updates will be listed below
-
Authors
Harder, Helena https://orcid.org/0000-0002-7296-8227
Starkings, Rachel https://orcid.org/0000-0002-1947-018X
Fallowfield, Lesley https://orcid.org/0000-0003-0577-4518
May, Shirley https://orcid.org/0000-0002-3167-9891
Shilling, Valerie https://orcid.org/0000-0002-5610-0321
-
Funding
Funding for this research was provided by:
Eli Lilly, United Kingdom (13Y-NS-O013, 13Y-NS-O013, 13Y-NS-O013, 13Y-NS-O013, 13Y-NS-O013)
- License Information
-
More Information
Article History
Received: 1 November 2024
Accepted: 7 April 2025
First Online: 26 April 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was granted by the NHS Health Research Authority (Tyne & Wear South Research Ethics Committee, reference number 20/NE/0101).
: Informed consent was obtained from all individual participants included in the study, and a statement is included in the manuscript.
: NA.
: The authors declare no competing interests.
